dronabinol has been researched along with Spinal Cord Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daniel, RT; Maduri, R; Messerer, M; Pralong, E | 1 |
| Dittrich, A; Henn, V; Hofmann, A; Maurer, M | 1 |
1 trial(s) available for dronabinol and Spinal Cord Neoplasms
| Article | Year |
|---|---|
Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial.
Topics: Adult; Double-Blind Method; Dronabinol; Ependymoma; Humans; Male; Neurologic Examination; Pain Measurement; Paraparesis, Tropical Spastic; Paresthesia; Postoperative Complications; Spinal Cord Neoplasms | 1990 |
1 other study(ies) available for dronabinol and Spinal Cord Neoplasms
| Article | Year |
|---|---|
Cannabinoid-induced alteration of motor-evoked potentials (MEPs) prior to intradural spinal tumor removal: a nasty surprise.
Topics: Analgesics; Cannabidiol; Child; Dronabinol; Drug Combinations; Evoked Potentials, Motor; Female; Humans; Intraoperative Neurophysiological Monitoring; Neurofibromatosis 1; Spinal Cord Neoplasms | 2018 |